1AD 4.76% 2.2¢ adalta limited

Ann: AD-214 pathway to IPF efficacy studies, page-54

  1. 1,514 Posts.
    lightbulb Created with Sketch. 503
    This is a real blow-out in the timeline. I know they are saying that they hope to be at phase II at roughly the same time as previously planned. But we were initially going to have phase I efficacy data to at least give us an idea of whether it worked in IPF in humans.

    Now it's 3-4 years before we have any efficacy data.
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.001(4.76%)
Mkt cap ! $13.33M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $4.295K 197.6K

Buyers (Bids)

No. Vol. Price($)
1 238937 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 810000 2
View Market Depth
Last trade - 14.21pm 06/09/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.